Mother and son jogging Mother and son jogging Mother and son jogging Mother and son jogging
Abbott Names Robert B. Ford Chairman of the Board; Miles D. White to Retire as Executive Chairman

ABBOTT PARK, Ill., Dec. 10, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced that its Board of Directors has elected Chief Executive Officer Robert B. Ford as Chairman of the Board, effective today. Miles D. White, executive chairman and former CEO, will step down from the Abbott Board effective today and will retire after a remarkable 38-year career with the Company.

"We're grateful for Miles' leadership and his exceptional work to transform Abbott into the leading health technology company that it is today," said William A. Osborn, lead director and chair of the Nominations and Governance committee. "Robert has continued to strengthen Abbott's position by advancing our industry-leading pipeline while managing the Company's significant contributions during the pandemic."

"It's been my privilege to serve Abbott and its many stakeholders, reshaping the Company to keep it relevant and strong while medicine, technology and society have evolved," said Mr. White. "Abbott will be in good hands with Robert's leadership, and I want to thank the Board and my colleagues – current and past – for their support during my tenure."

"I want to thank Miles for all he's done for Abbott and the people we serve, as well as his mentorship and friendship throughout my career," said Mr. Ford. "It's my honor to work alongside the Board and my global team to deliver on the unprecedented opportunities in front of us, so Abbott continues to lead in the reshaping of the future of healthcare."

About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

Connect with us at, on LinkedIn at, on Facebook at and on Twitter @AbbottNews.


For further information: Abbott Financial: Scott Leinenweber, 224-668-0791; Abbott Media: Scott Stoffel, 224-668-5201

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?


You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.

The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?